CANCER TREATMENT WITH HER2XCD3 BISPECIFIC ANTIBODIES IN COMBINATION WITH AN ANTI-HER2 MAB
MA55296AUndetermined Publication Date: 2022-03-23F HOFFMANN LA ROCHE & CO AG
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- MA55296
- Authority / Receiving Office
- MA · MA
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2019-03-14
- Filing Date
- 2020-03-13
- Publication Date
- 2022-03-23
Need to check novelty before this filing date? Find Prior Art
No text content released.